ATE540974T1 - Reinigung des rekombinanten menschlichen faktors xiii - Google Patents

Reinigung des rekombinanten menschlichen faktors xiii

Info

Publication number
ATE540974T1
ATE540974T1 AT05815706T AT05815706T ATE540974T1 AT E540974 T1 ATE540974 T1 AT E540974T1 AT 05815706 T AT05815706 T AT 05815706T AT 05815706 T AT05815706 T AT 05815706T AT E540974 T1 ATE540974 T1 AT E540974T1
Authority
AT
Austria
Prior art keywords
factor xiii
less
methods
affinity chromatography
purification
Prior art date
Application number
AT05815706T
Other languages
English (en)
Inventor
Carol Jewell
Hardarshan Cheema
Deborah Hogg
Wenmao Meng
Ray O'donnell
Ewan Robertson
Andrew Topping
Original Assignee
Zymogenetics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zymogenetics Inc filed Critical Zymogenetics Inc
Application granted granted Critical
Publication of ATE540974T1 publication Critical patent/ATE540974T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
AT05815706T 2004-11-23 2005-11-23 Reinigung des rekombinanten menschlichen faktors xiii ATE540974T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US63061404P 2004-11-23 2004-11-23
PCT/EP2005/056169 WO2006056575A1 (en) 2004-11-23 2005-11-23 Purification of recombinant human factor xiii

Publications (1)

Publication Number Publication Date
ATE540974T1 true ATE540974T1 (de) 2012-01-15

Family

ID=35717653

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05815706T ATE540974T1 (de) 2004-11-23 2005-11-23 Reinigung des rekombinanten menschlichen faktors xiii

Country Status (9)

Country Link
US (1) US8461302B2 (de)
EP (1) EP1817339B1 (de)
JP (1) JP5086093B2 (de)
AT (1) ATE540974T1 (de)
AU (1) AU2005308830B2 (de)
CA (1) CA2587139C (de)
ES (1) ES2378777T3 (de)
IL (1) IL182830A (de)
WO (1) WO2006056575A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2743346A1 (de) * 2012-12-11 2014-06-18 Zedira GmbH Kristallstruktur des Blutgerinnungsfaktors XIIIa
CN110314414B (zh) * 2019-07-23 2021-10-19 宝锐生物科技泰州有限公司 凝血因子xiii的分离纯化方法及其应用

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3904751A (en) 1970-12-22 1975-09-09 Behringwerke Ag Process for isolating a fibrin stabilizing factor from human placenta
US3931399A (en) 1970-12-22 1976-01-06 Behringwerke Aktiengesellschaft Process for isolating a fibrin-stabilizing factor
US4265233A (en) * 1978-04-12 1981-05-05 Unitika Ltd. Material for wound healing
AT359652B (de) * 1979-02-15 1980-11-25 Immuno Ag Verfahren zur herstellung eines gewebekleb- stoffes
AT359653B (de) 1979-02-15 1980-11-25 Immuno Ag Verfahren zur herstellung eines gewebekleb- stoffes
DE3105624A1 (de) 1981-02-16 1982-09-02 Hormon-Chemie München GmbH, 8000 München Material zum abdichten und heilen von wunden
AT369990B (de) 1981-07-28 1983-02-25 Immuno Ag Verfahren zur herstellung eines gewebeklebstoffes
DE3419581A1 (de) 1984-05-25 1985-11-28 Behringwerke Ag, 3550 Marburg Verfahren zur gewinnung einer faktor xiii-praeparation sowie ihre verwendung
DE3621371A1 (de) 1986-03-12 1987-09-17 Behringwerke Ag Gentechnische herstellung von faktor xiiia
EP0268772B1 (de) 1986-09-19 1995-04-26 ZymoGenetics, Inc. Expression des biologisch aktiven Faktors XIII
JPS63196520A (ja) 1987-02-09 1988-08-15 Hoechst Japan Kk 潰瘍性大腸炎治療剤
JPH01216939A (ja) * 1988-02-24 1989-08-30 Hoechst Japan Kk 末熟児頭蓋内出血阻止剤
US5204447A (en) 1988-11-14 1993-04-20 Zymogenetics, Inc. Purification of factor xiii
US5612456A (en) * 1988-11-14 1997-03-18 Zymogenetics, Inc. Factor XIII compositions
JPH02247199A (ja) * 1989-03-17 1990-10-02 Green Cross Corp:The ヒト血液凝固第ｘ３因子の製造法
WO1991014780A1 (en) 1990-03-21 1991-10-03 Board Of Regents, The University Of Texas System Yeast expression vectors
DK0603215T3 (da) 1991-08-07 1997-12-01 Zymogenetics Inc Oprensning af faktor XIII
WO1993012813A1 (en) 1991-12-31 1993-07-08 Zymogenetics, Inc. Methods and compositions for reducing blood loss
JP3195439B2 (ja) * 1992-09-28 2001-08-06 森永製菓株式会社 第ｘｉｉｉ因子の精製方法
JP2004505016A (ja) 2000-05-10 2004-02-19 ノボ　ノルディスク　アクティーゼルスカブ 第ＶＩＩａ因子及び第ＸＩＩＩ因子を含んで成る医薬組成物
US20040014657A1 (en) * 2001-11-05 2004-01-22 Jan Ohrstrom Use of blood coagulation factor XIII for treating haemophilia A
ES2282319T3 (es) 2000-11-03 2007-10-16 Zymogenetics, Inc. Uso de factor xiii de coagulacion sanguinea para tratar la hemofilia a.
US20040033947A1 (en) * 2001-11-08 2004-02-19 Jan Ohrstrom Method for treating hemophilia b
AU2002226004A1 (en) 2000-11-10 2002-05-21 Zymogenetics Inc. Use of factor xiii for treating hemophilia b
US7008926B2 (en) * 2001-02-22 2006-03-07 Zymogenetics Inc. Blood coagulation factor XIII for treating platelet disorders
GB0216001D0 (en) * 2002-07-10 2002-08-21 Nat Blood Authority Process and composition
JP2004123566A (ja) 2002-09-30 2004-04-22 Nihon Pharmaceutical Co Ltd ヒト血漿由来血液凝固第ｘｉｉｉ因子製剤およびその製造方法
CU23475A1 (es) * 2004-07-08 2009-12-17 Ct Ingenieria Genetica Biotech Composición farmacéutica conteniendo fragmentos polipeptídicos de serralisinas
EP1784415A2 (de) * 2004-08-27 2007-05-16 Novo Nordisk Health Care AG Reinigung von faktor xiii-polypeptiden aus biologischen materialien

Also Published As

Publication number Publication date
EP1817339B1 (de) 2012-01-11
US20080281080A1 (en) 2008-11-13
AU2005308830B2 (en) 2012-01-19
CA2587139A1 (en) 2006-06-01
US8461302B2 (en) 2013-06-11
EP1817339A1 (de) 2007-08-15
JP2008520220A (ja) 2008-06-19
IL182830A (en) 2013-12-31
CA2587139C (en) 2014-05-27
WO2006056575A1 (en) 2006-06-01
ES2378777T3 (es) 2012-04-17
IL182830A0 (en) 2007-08-19
AU2005308830A1 (en) 2006-06-01
JP5086093B2 (ja) 2012-11-28

Similar Documents

Publication Publication Date Title
GB2364059A (en) Beta-Secretase enzyme compositions and methods
RU2011137030A (ru) Способы очистки малых модулярных иммунофармацевтических белков
GB0117326D0 (en) Napthoquinone-type inhibitors of protein aggregation
ES2170104T3 (es) Inhibidores de la produccion de proteinas de beta-amiloide.
NZ598395A (en) Methods for purification of alpha-1-antitrypsin and apolipoprotein A-I
TNSN08064A1 (en) Albumin fusion proteins
EA200200293A1 (ru) Бициклические аминокислоты в качестве фармацевтических агентов
SG162806A1 (en) Methods of purifying anti a beta antibodies
EP1408986A4 (de) Proteomimetische verbindungen und verfahren
ME00116B (me) Piperazin sa ili supstituisanom fenil grupom i njihova upotreba kao inhibitora glyt1
BRPI0410685B8 (pt) processos de purificação do 1,3-propanodiol e composição
PE20150720A1 (es) Purificacion de iduronato-2-sulfatasa
NO20011891L (no) Anvendelse av radioligander for screening av inhibitorer av amyloid-<beta>-peptid produksjon
BR0312521A (pt) Métodos para a separação e a purificação de fibrinogênio e de pelo menos uma outra proteìna e para a co-purificação de fibrinogênio e de fator xiii, uso de cromatografia de afinidade com ìon de metal imobilizado, fibrinogênio, kit farmacêutico, e, formulações farmacêutica e de fibrinogênio liofilizado
WO2004029072A3 (en) PrPsc -INTERACTING MOLECULES AND USES THEREOF
WO2009063503A3 (en) Process for purification of human tissue type plasminogen activator
HUP0204231A2 (hu) Eljárás hCG tisztítására és az eljárással tisztított rekombináns hCG
WO2004026891A3 (en) Protein purification
HK1121670A1 (en) Preparation and composition of inter-alpha inhibitor proteins from human plasma for therapeutic use
ATE540974T1 (de) Reinigung des rekombinanten menschlichen faktors xiii
ATE509028T1 (de) Ionen-austausch-chromatographische trennung von glp-1 und verwandten peptiden
WO2005042777A3 (en) App/ena antisense
WO2006019804A3 (en) Compositions and methods of purifying myelin-associated glycoprotein (mag)
AR042019A1 (es) N-acetilgalactosamina-4-sulfatasa precursora, composiciones farmaceuticas que la contienen , metodos de tratamiento que la utilizan y metodos para producirla y purificarla
ATE522617T1 (de) Verfahren zur aufreinigung von interferon-beta